Physician profile
John A Volpe
NPI 1558324764
$4,041.12
in general payments reported to CMS, 2019-2025
43 companies · $500 in 2025
The $500 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $844 · 2020: $288 · 2021: $377 · 2022: $893 · 2023: $680 · 2024: $459 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,638.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $648.16 | 2019-2025 | Grafix Pl, Stravix, Collagenase Santyl |
| Paratek Pharmaceuticals, INC. | $260.94 | 2020-2025 | Nuzyra |
| Orthofix Medical, INC. | $233.65 | 2019-2025 | Physio-Stim |
| Medtronic, INC. | $229.91 | 2022-2025 | In.Pact Admiral, Intellis Adaptivestim |
| Osteomed LLC | $184.20 | 2019-2022 | |
| Acumed LLC | $178.48 | 2022-2024 | Acumed, Osteomed, Inframe Implant |
| Kci USA, INC. | $167.26 | 2019-2022 | |
| Bioventus LLC | $164.43 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $147.05 | 2019 | |
| Integra Lifesciences Corporation | $123.65 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Cardiovascular Systems INC. | $122.76 | 2019 | |
| Stryker Corporation | $120.01 | 2024 | N/A, Ortholoc 2 Lapifuse, Prophecy |
| Dynasplint Systems INC. | $118.71 | 2020-2022 | |
| Tactile Systems Technology INC | $99.62 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Kerecis Limited | $96.40 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $91.30 | 2022 | |
| Treace Medical Concepts, INC. | $87.99 | 2022 | |
| Ani Pharmaceuticals, INC. | $86.18 | 2023-2025 | Purified Cortrophin Gel |
| Nevro Corp. | $81.01 | 2022-2023 | Senza |
| Ibsa Pharma INC. | $79.29 | 2023-2025 | Licart, Tirosint, Flector |
| Organogenesis INC. | $71.42 | 2020-2023 | Puraply |
| Shockwave Medical, INC | $71.33 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Averitas Pharma INC. | $67.03 | 2023-2025 | Qutenza |
| Sebela Pharmaceuticals INC. | $53.82 | 2020-2023 | Naftin |
| Nabriva Therapeutics, Plc | $47.86 | 2021-2022 | |
| Bone Support INC. | $41.25 | 2025 | Ceramentbone Void Filler, Cerament G |
| Amgen INC. | $38.42 | 2024-2025 | Krystexxa |
| Melinta Therapeutics, LLC | $35.07 | 2019 | |
| Abbvie INC. | $30.64 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $30.51 | 2022-2023 | Seglentis |
| Merck Sharp & Dohme LLC | $26.06 | 2019 | |
| Mimedx Group, INC. | $22.88 | 2024 | |
| Lifenet Health | $21.81 | 2024 | Theragenesis Wound Matrix |
| Heron Therapeutics, INC. | $18.94 | 2021 | |
| Allergan, INC. | $18.56 | 2020 | |
| Triad Life Sciences INC. | $18.55 | 2022 | |
| Osiris Therapeutics INC. | $18.00 | 2019 | |
| Derma Sciences, INC. | $16.95 | 2019 | |
| Alfasigma USA, INC. | $16.90 | 2021 | |
| Reprise Biomedical, INC. | $15.62 | 2024 | Miro3d |
| Ebi, LLC | $13.89 | 2025 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System, Biomet Ebi Bone Healing System, Ebi Osteogen Implantable Bone Growth Stimulator |
| Solventum Corporation | $13.52 | 2024 | Activ.A.C. |
| Medline Industries LP | $11.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Volpe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.